Expertise in
20
conditions

Gerald F. Watts

35 Stirling Highway, 
Crawley, WA, AU 
Expertise in
20
conditions
35 Stirling Highway, 
Crawley, WA, AU 

Overview

Gerald Watts practices practicing medicine in Crawley, Australia.

Mr. Watts is highly rated in 20 conditions, according to our data. His clinical expertise encompasses High Cholesterol, Familial Hypercholesterolemia, Familial Hypertriglyceridemia, Defective Apolipoprotein B-100, and Liver Transplant.

He is actively involved in clinical research, co-authoring 890 peer reviewed articles and participating in 8 clinical trials.

Gender

Male

Locations

35 Stirling Highway, Crawley, WA 6009, Australia
Other Locations
35 Stirling Highway, Nedlands, WA 6009, Australia
197 Wellington Street, Perth, WA 6000, Australia
Level 4, Rear 50 Murray Street, Perth, WA 6000, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Randomized, Double Blind, Placebo Controlled, Multicenter, Multiple Ascending Dose Study to Evaluate the Safety and Tolerability of HTD1801 in Adults With Hypercholesterolemia
A Randomized, Double Blind, Placebo Controlled, Multicenter, Multiple Ascending Dose Study to Evaluate the Safety and Tolerability of HTD1801 in Adults With Hypercholesterolemia
Enrollment Status: Completed
Publish Date: August 11, 2026
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
Phase 2 Study to Evaluate the Safety and Efficacy of ARO-ANG3 in Subjects With Homozygous Familial Hypercholesterolemia (HOFH)
Phase 2 Study to Evaluate the Safety and Efficacy of ARO-ANG3 in Subjects With Homozygous Familial Hypercholesterolemia (HOFH)
Enrollment Status: Terminated
Publish Date: June 12, 2026
Intervention Type: Drug
Study Drug: ARO-ANG 3
Study Phase: Phase 2
A Phase 3 Study to Evaluate the Efficacy and Safety of ARO-APOC3 in Adults With Familial Chylomicronemia Syndrome
A Phase 3 Study to Evaluate the Efficacy and Safety of ARO-APOC3 in Adults With Familial Chylomicronemia Syndrome
Enrollment Status: Completed
Publish Date: June 05, 2026
Intervention Type: Drug
Study Drug: ARO-APOC3
Study Phase: Phase 3
A Phase 2 Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of ARO-APOC3 in Adults With Dyslipidemia
A Phase 2 Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of ARO-APOC3 in Adults With Dyslipidemia
Enrollment Status: Completed
Publish Date: May 12, 2026
Intervention Type: Drug
Study Phase: Phase 2
A Double-Blind, Placebo-Controlled Phase 2b Study to Evaluate the Efficacy and Safety of ARO-APOC3 in Adults With Severe Hypertriglyceridemia
A Double-Blind, Placebo-Controlled Phase 2b Study to Evaluate the Efficacy and Safety of ARO-APOC3 in Adults With Severe Hypertriglyceridemia
Enrollment Status: Completed
Publish Date: March 24, 2026
Intervention Type: Drug
Study Drug: ARO-APOC3
Study Phase: Phase 2
A Phase 1 Single and Multiple Dose-Escalating Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects of ARO-APOC3 in Adult Healthy Volunteers as Well as in Severely Hypertriglyceridemic Patients and Patients With Familial Chylomicronemia Syndrome
A Phase 1 Single and Multiple Dose-Escalating Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects of ARO-APOC3 in Adult Healthy Volunteers as Well as in Severely Hypertriglyceridemic Patients and Patients With Familial Chylomicronemia Syndrome
Enrollment Status: Completed
Publish Date: December 24, 2025
Intervention Type: Drug
Study Phase: Phase 1
A Phase 1 Single and Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects of ARO-ANG3 in Adult Healthy Volunteers and in Dyslipidemic Patients
A Phase 1 Single and Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects of ARO-ANG3 in Adult Healthy Volunteers and in Dyslipidemic Patients
Enrollment Status: Completed
Publish Date: December 24, 2025
Intervention Type: Drug
Study Drug: ARO-ANG3
Study Phase: Phase 1
A Double-blind, Placebo-controlled Phase 2b Study to Evaluate the Efficacy and Safety of ARO-ANG3 in Adults With Mixed Dyslipidemia
A Double-blind, Placebo-controlled Phase 2b Study to Evaluate the Efficacy and Safety of ARO-ANG3 in Adults With Mixed Dyslipidemia
Enrollment Status: Completed
Publish Date: December 03, 2025
Intervention Type: Drug
Study Phase: Phase 2
View 7 Less Clinical Trials

889 Total Publications

Feasibility and outcomes of the DNA Screen nationwide adult genomic screening pilot.
Feasibility and outcomes of the DNA Screen nationwide adult genomic screening pilot.
Journal: Nature health
Published: August 26, 2026

Frequently Asked Questions about Gerald F. Watts

Is Gerald F. Watts a top-rated expert for High Cholesterol?

MediFind is an objective health platform that identifies experts based on real-world data. Gerald F. Watts is classified as an Elite expert for High Cholesterol, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Gerald F. Watts participate in research or clinical trials?

Yes. Gerald F. Watts has published 889 articles and abstracts on conditions like High Cholesterol. You can view a list of Gerald F. Watts's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Watts's expertise for a condition
ConditionClose
View All 7 Elite Conditions
View All 9 Advanced Conditions
View All 29 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile